排名 |
分析师 |
机构 |
行业 |
年度收益率
|
6个月收益率
|
3个月收益率
|
正收益比例
|
成分股数量
|
历史最大跌幅
|
更新日期
|
1 |
胡晨曦
|
长城国瑞证券 |
医药生物 |
65.77%
|
61.54%
|
28.01%
|
3.45%
|
7 |
-27.10%
|
2025-06-19 |
2 |
胡晨曦
|
长城国瑞证券 |
医药生物 |
65.76%
|
63.11%
|
35.39%
|
3.45%
|
7 |
-27.10%
|
2025-06-24 |
3 |
胡晨曦
|
长城国瑞证券 |
医药生物 |
65.71%
|
65.15%
|
38.40%
|
3.45%
|
7 |
-27.10%
|
2025-06-26 |
4 |
李安飞
|
广发证券 |
医药生物 |
65.70%
|
73.28%
|
32.01%
|
2.86%
|
0 |
-56.96%
|
2025-07-10 |
5 |
李安飞
|
广发证券 |
医药生物 |
65.70%
|
63.19%
|
31.12%
|
2.86%
|
0 |
-56.96%
|
2025-06-20 |
6 |
李安飞
|
广发证券 |
医药生物 |
65.70%
|
57.26%
|
42.67%
|
2.86%
|
0 |
-56.96%
|
2025-06-16 |
7 |
李安飞
|
广发证券 |
医药生物 |
65.70%
|
61.76%
|
33.80%
|
2.86%
|
0 |
-56.96%
|
2025-07-17 |
8 |
李安飞
|
广发证券 |
医药生物 |
65.70%
|
68.73%
|
35.84%
|
2.86%
|
0 |
-56.96%
|
2025-07-09 |
9 |
李安飞
|
广发证券 |
医药生物 |
65.70%
|
61.52%
|
11.88%
|
2.86%
|
0 |
-56.96%
|
2025-07-28 |
10 |
李安飞
|
广发证券 |
医药生物 |
65.70%
|
70.58%
|
37.85%
|
2.86%
|
0 |
-56.96%
|
2025-07-08 |
11 |
李安飞
|
广发证券 |
医药生物 |
65.70%
|
58.82%
|
39.79%
|
2.86%
|
0 |
-56.96%
|
2025-06-17 |
12 |
李安飞
|
广发证券 |
医药生物 |
65.70%
|
65.70%
|
23.82%
|
2.86%
|
0 |
-56.96%
|
2025-07-01 |
13 |
李安飞
|
广发证券 |
医药生物 |
65.70%
|
60.19%
|
13.52%
|
2.86%
|
0 |
-56.96%
|
2025-07-25 |
14 |
李安飞
|
广发证券 |
医药生物 |
65.70%
|
64.75%
|
28.71%
|
2.86%
|
0 |
-56.96%
|
2025-06-30 |
15 |
李安飞
|
广发证券 |
医药生物 |
65.70%
|
64.63%
|
37.61%
|
2.86%
|
0 |
-56.96%
|
2025-06-24 |
16 |
李安飞
|
广发证券 |
医药生物 |
65.70%
|
68.47%
|
23.49%
|
2.86%
|
0 |
-56.96%
|
2025-07-04 |
17 |
李安飞
|
广发证券 |
医药生物 |
65.70%
|
63.07%
|
34.98%
|
2.86%
|
0 |
-56.96%
|
2025-06-19 |
18 |
李安飞
|
广发证券 |
医药生物 |
65.70%
|
65.02%
|
28.99%
|
2.86%
|
0 |
-56.96%
|
2025-07-15 |
19 |
李安飞
|
广发证券 |
医药生物 |
65.70%
|
67.31%
|
38.59%
|
2.86%
|
0 |
-56.96%
|
2025-06-25 |
20 |
李安飞
|
广发证券 |
医药生物 |
65.70%
|
73.28%
|
27.68%
|
2.86%
|
0 |
-56.96%
|
2025-07-11 |